Cite
Kaczor MP, Pawlik D, Wójcik R, et al. Budget Impact Analysis of Aflibercept in yhe Treatment of Metastatic Colorectal Cancer (MCRC) in Poland. Value Health. 2014;17(7):A621doi: 10.1016/j.jval.2014.08.2199.
Kaczor, M. P., Pawlik, D., Wójcik, R., Glasek, M., Pieczonka, A., Kraska, A., & Zelazowski, K. (2014). Budget Impact Analysis of Aflibercept in yhe Treatment of Metastatic Colorectal Cancer (MCRC) in Poland. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A621. https://doi.org/10.1016/j.jval.2014.08.2199
Kaczor, M P, et al. "Budget Impact Analysis of Aflibercept in yhe Treatment of Metastatic Colorectal Cancer (MCRC) in Poland." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A621. doi: https://doi.org/10.1016/j.jval.2014.08.2199
Kaczor MP, Pawlik D, Wójcik R, Glasek M, Pieczonka A, Kraska A, Zelazowski K. Budget Impact Analysis of Aflibercept in yhe Treatment of Metastatic Colorectal Cancer (MCRC) in Poland. Value Health. 2014 Nov;17(7):A621. doi: 10.1016/j.jval.2014.08.2199. Epub 2014 Oct 26. PMID: 27202185.
Copy
Download .nbib